Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:346-353

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flesch, M.
Right arrow Articles by Böhm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flesch, M.
Right arrow Articles by Böhm, M.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell signalling/signal transduction
Right arrow Myocardial cardiomyopathy disease

(Circulation. 1999;100:346-353.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Effect of ß-Blockers on Free Radical–Induced Cardiac Contractile Dysfunction

M. Flesch, MD; C. Maack, MS; B. Cremers, MS; A. T. Bäumer, MD; M. Südkamp, MD; M. Böhm, MD

From the Klinik III für Innere Medizin and Klinik für Herz- und Thoraxchirurgie (M.S.) der Universität zu Köln, Cologne, Germany. Dr Flesch and C. Maack contributed equally to the article.

Correspondence to M. Flesch, MD, Joseph-Stelzmann-Straße 9, 50924 Cologne, Germany.

Background—We examined the effects of hydroxyl radicals (OH·) on human myocardial contractility and on sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity and the effects of the ß-receptor antagonists metoprolol, carvedilol, and its metabolite BM-910228.

Methods and Results—Isometric force of contraction was determined in isolated human myocardium. H2O2 1 mmol/L and Fe3+-nitrilotriacetic acid (Fe3+-NTA) 0.1 mmol/L used for generation of OH· induced a decrease in basal force of contraction and an increase in diastolic tension in atrial and left ventricular myocardial preparations. After challenge with OH·, the maximum positive inotropic response to Ca2+ 1.8 to 15 mmol/L was decreased by 60% and by 39%, respectively. The effects of OH· could be blocked by catalase. Carvedilol and its metabolite BM-910228 attenuated the OH·-induced impairment of the inotropic response to Ca2+ in atrial myocardial preparations. Metoprolol had no significant effect. The stimulation frequency (0.5 to 3.0 Hz)–dependent increase in force of contraction and decrease in diastolic tension were abolished after exposure of atrial trabeculae to OH·. In parallel, SERCA activity was decreased by OH· concentration-dependently, as determined in myocardial membrane preparations. BM-910228 partially restored the force-frequency relationship and preserved SERCA activity.

Conclusions—OH· radicals induce an impairment of contraction and relaxation and an attenuation of the force-frequency relationship in human myocardium accompanied by an inhibition of SERCA. Carvedilol and BM-910228 partly prevented OH·-induced contractile dysfunction. These observations could explain the improvement of ejection fraction in heart failure trials with carvedilol without a restoration of ß-adrenergic receptor density.


Key Words: heart failure • contractility • free radicals • receptors, adrenergic, beta




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. T. Baumer, H. ten Freyhaus, H. Sauer, M. Wartenberg, K. Kappert, P. Schnabel, C. Konkol, J. Hescheler, M. Vantler, and S. Rosenkranz
Phosphatidylinositol 3-Kinase-dependent Membrane Recruitment of Rac-1 and p47phox Is Critical for {alpha}-Platelet-derived Growth Factor Receptor-induced Production of Reactive Oxygen Species
J. Biol. Chem., March 21, 2008; 283(12): 7864 - 7876.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Brixius, R. Lu, B. Boelck, S. Grafweg, F. Hoyer, C. Pott, U. Mehlhorn, W. Bloch, and R. H. G. Schwinger
Chronic Treatment with Carvedilol Improves Ca2+-Dependent ATP Consumption in Triton X-Skinned Fiber Preparations of Human Myocardium
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S. M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, et al.
Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction
Circ. Res., March 30, 2007; 100(6): 894 - 903.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Hiranandani, T. Bupha-Intr, and P. M. L. Janssen
SERCA overexpression reduces hydroxyl radical injury in murine myocardium
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3130 - H3135.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Kalay, E. Basar, I. Ozdogru, O. Er, Y. Cetinkaya, A. Dogan, T. Inanc, A. Oguzhan, N. K. Eryol, R. Topsakal, et al.
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
J. Am. Coll. Cardiol., November 8, 2006; (2006) j.jacc.2006.07.052v1.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
B. Preckel, D. Obal, J. Mullenheim, J. Hennes, M. Heiderhoff, V. Thamer, and W. Schlack
Effects of halothane, sevoflurane and desflurane on the force-frequency relation in the dog heart in vivo: [Les effets de l'halothane, du sevoflurane et du desflurane sur la relation force-frequence des coeurs de chiens in vivo].
Can J Anesth, November 1, 2006; 53(11): 1118 - 1125.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Wang, T. Miura, N. Harada, R. Kametani, M. Shibuya, Y. Fukagawa, S. Kawamura, Y. Ikeda, M. Hara, and M. Matsuzaki
Pleiotropic Effects of the beta-Adrenoceptor Blocker Carvedilol on Calcium Regulation during Oxidative Stress-Induced Apoptosis in Cardiomyocytes
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Disruption of the ventricular myocardial force-frequency relationship after cardiac surgery in children: noninvasive assessment by means of tissue Doppler imaging.
J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 625 - 631.



Home page
JNMHome page
A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet
Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure
J. Nucl. Med., November 1, 2005; 46(11): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y.-L. Sun, S.-J. Hu, L.-H. Wang, Y. Hu, and J.-Y. Zhou
Effect of {beta}-Blockers on Cardiac Function and Calcium Handling Protein in Postinfarction Heart Failure Rats
Chest, September 1, 2005; 128(3): 1812 - 1821.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
S. K. Hamlin, P. S. Villars, J. T. Kanusky, and A. D. Shaw
Role of Diastole in Left Ventricular Function, II: Diagnosis and Treatment
Am. J. Crit. Care., November 1, 2004; 13(6): 453 - 466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yuan, K. Shioji, Y. Kihara, H. Takenaka, Y. Onozawa, and C. Kishimoto
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H83 - H90.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Drent, A. P. Gorgels, and A. Bast
Cardiac Failure Associated With G6PD Deficiency
Circ. Res., October 17, 2003; 93 (8): e75 - e75.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S.-P. Yang, L.-J. Ho, Y.-L. Lin, S.-M. Cheng, T.-P. Tsao, D.-M. Chang, Y.-L. Hsu, C.-Y. Shih, T.-Y. Juan, and J.-H. Lai
Carvedilol, a new antioxidative {beta}-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-{kappa}B activity
Cardiovasc Res, September 1, 2003; 59(3): 776 - 787.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Nakamura, K. Kusano, Y. Nakamura, M. Kakishita, K. Ohta, S. Nagase, M. Yamamoto, K. Miyaji, H. Saito, H. Morita, et al.
Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium
Circulation, June 18, 2002; 105(24): 2867 - 2871.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
O. Zeitz, A. E. Maass, P. Van Nguyen, G. Hensmann, H. Kogler, K. Moller, G. Hasenfuss, and P. M.L. Janssen
Hydroxyl Radical-Induced Acute Diastolic Dysfunction Is Due to Calcium Overload via Reverse-Mode Na+-Ca2+ Exchange
Circ. Res., May 17, 2002; 90(9): 988 - 995.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F Boomsma, P.J de Kam, G Tjeerdsma, A.H van Den Meiracker, and D.J van Veldhuisen
Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
Eur. Heart J., November 2, 2000; 21(22): 1859 - 1863.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
L.-M. Hung, J.-K. Chen, S.-S. Huang, R.-S. Lee, and M.-J. Su
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
Cardiovasc Res, August 18, 2000; 47(3): 549 - 555.
[Abstract] [Full Text] [PDF]